ONRELTEA
GALDERMA CANADA INC.
Quick answers
Is there a shortage of ONRELTEA in Canada?
No. There is no current shortage of ONRELTEA 0.33% reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
ALPHAGAN
ABBVIE CORPORATION
ALPHAGAN P
ABBVIE CORPORATION
MED-BRIMONIDINE
GENERIC MEDICAL PARTNERS INC
LUMIFY
BAUSCH & LOMB INC
SANDOZ BRIMONIDINE
SANDOZ CANADA INCORPORATED
RIVA-BRIMONIDINE
LABORATOIRE RIVA INC.
DIN
02421208
Strength
0.33%
Dosage Form
GEL
Route
TOPICAL
Compare with another product →
Product Monograph
Product monograph is not available from Health Canada
Shortage History
Other Products from GALDERMA CANADA INC.
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
50MCG · DIN 02494175
40MG · DIN 02375885
10% · DIN 01925199
DIN 02315831
DIN 02243329
DIN 02374536
0.05% · DIN 02256371
0.05% · DIN 02299739
0.1% · DIN 02231592
0.1% · DIN 02148749
0.3% · DIN 02274000
0.75% · DIN 02092832